Patents by Inventor Wei-Ya Lin
Wei-Ya Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240088293Abstract: An n-type metal oxide semiconductor transistor includes a gate structure, two source/drain regions, two amorphous portions and a silicide. The gate structure is disposed on a substrate. The two source/drain regions are disposed in the substrate and respectively located at two sides of the gate structure, wherein at least one of the source/drain regions is formed with a dislocation. The two amorphous portions are respectively disposed in the two source/drain regions. The silicide is disposed on the two source/drain regions, wherein at least one portion of the silicide overlaps the two amorphous portions.Type: ApplicationFiled: October 5, 2022Publication date: March 14, 2024Applicant: UNITED MICROELECTRONICS CORP.Inventors: Chun-Ya Chiu, Ssu-I Fu, Chin-Hung Chen, Jin-Yan Chiou, Wei-Chuan Tsai, Yu-Hsiang Lin
-
Patent number: 10101340Abstract: Described is a method of detecting a protein fragment in a urine sample and a serum sample. The protein fragment is a urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragment. The urine sample and the serum sample are obtained from the same individual.Type: GrantFiled: May 24, 2013Date of Patent: October 16, 2018Assignee: Bio Preventive Medicine Corp.Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 9983216Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing and staging liver fibrosis.Type: GrantFiled: September 15, 2017Date of Patent: May 29, 2018Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Publication number: 20180003722Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing and staging liver fibrosis.Type: ApplicationFiled: September 15, 2017Publication date: January 4, 2018Inventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Patent number: 9791460Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing liver fibrosis.Type: GrantFiled: December 13, 2013Date of Patent: October 17, 2017Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Patent number: 9442120Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: June 7, 2013Date of Patent: September 13, 2016Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20140106370Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing liver fibrosis.Type: ApplicationFiled: December 13, 2013Publication date: April 17, 2014Applicant: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hong-Yi Li, Ye-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh
-
Publication number: 20130266976Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: June 7, 2013Publication date: October 10, 2013Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20130252267Abstract: Described are uses of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: May 24, 2013Publication date: September 26, 2013Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8476077Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: December 15, 2010Date of Patent: July 2, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8470547Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: December 16, 2010Date of Patent: June 25, 2013Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Patent number: 8465980Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: January 27, 2010Date of Patent: June 18, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110086372Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20110086371Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110079077Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110081668Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 16, 2010Publication date: April 7, 2011Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE(ITRI)Inventors: MARY YA-PING YEH, TZU-LING TSENG, CHING-FANG LU, WEI-YA LIN, TSAI-WEI HSU, YI-TING CHEN, CHWEI-SHIUN YANG
-
Publication number: 20110081667Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20100209948Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: January 27, 2010Publication date: August 19, 2010Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20100197033Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: January 27, 2010Publication date: August 5, 2010Applicant: Industrial Technology Research Institute (ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20100136579Abstract: Identification of urokinase-type plasminogen, matrix metalloproteinase 9, and ?-2-microglobulin as novel biomarkers associated with liver fibrosis and uses thereof in diagnosing liver fibrosis.Type: ApplicationFiled: December 1, 2009Publication date: June 3, 2010Applicant: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Hung-Yi Li, Yen-Peng Li, Angelina Huai-Lo Lee, Yi-Chen Liu, Ping-Fu Cheng, Wei-Ya Lin, Hong-Zen Yeh